A Phase 2 trial designed to test a self-administered inhaled formulation of nitric oxide (NO) for adults with chronic…
Articles by Patricia Inácio, PhD
Verona Pharma has completed patient enrollment for ENHANCE-2, a Phase 3 clinical trial evaluating the safety and efficacy of…
Adults with chronic obstructive pulmonary disease (COPD) are being recruited for a study into whether Wellinks’ first integrated…
Breathing exercises via a mobile app help improve respiratory muscle strength and mobility in the diaphragm in patients with severe…
Twenty years after the collapse the World Trade Center, rescue workers and volunteers who assisted at the site in the…
Smaller particles and optimal inhalation speed of inhaler treatments — a mainstay for people with chronic obstructive…
GoodRx, a platform for healthcare savings in the U.S., and pharmaceutical company Boehringer Ingelheim have teamed up to help…
Treatment with mepolizumab, an antibody designed to lower the levels of eosinophils — immune cells linked with worse chronic…
Approximately 40% of chronic obstructive pulmonary disease (COPD) patients in the U.S. — and notably, most of those living…
Note: This story was updated May 21, 2021, as an earlier version of this article misidentified Renu Jain, PhD,…